Video Interview: Jonathan Wolfson, Chief Executive Officer and Co-Founder, Solazyme, Inc.

NASDAQ CEO Signature Series Broadcasted From the NASDAQ MarketSite


NEW YORK, June 3, 2011 (GLOBE NEWSWIRE) -- Veteran business journalist Joya Dass joins Jonathan Wolfson, Chief Executive Officer and co-founder, Solazyme, Inc. (SZYM) to discuss the company's industry, strategy, financials and positioning.

Click here to view video:

http://investor.shareholder.com/ceosignature/webcast.cfm?mediaid=48075&k=1923FA7DB8EFB7431A11C1D9403C0E9C

Jonathan Wolfson, Chief Executive Officer and co-founder:

Mr. Wolfson is a co-founder of Solazyme and the company's Chief Executive Officer. Prior to founding Solazyme, Mr. Wolfson held a variety of positions in finance, business and law including at Triarc, and serving as co-founder and Chief Operating Officer of InvestorTree. Immediately prior to Solazyme, he was the Vice President of Finance and Business Development for 7thOnline, a supply chain software company.

Mr. Wolfson sits on the board of the Clean Economy Network, a green business advocacy association. He is also a member of the board of directors of the Biotechnology Industry Organization (BIO) and is on the governing board of BIO's Industrial and Environmental Section. Mr. Wolfson also serves on the Executive Council for the Advanced Biofuels Association (ABFA). Additionally, Jonathan is an inventor on five of Solazyme's patent applications.

Mr. Wolfson holds J.D. and M.B.A. degrees from the NYU School of Law and the NYU Stern School of Business. Additionally, he spent several years as an Adjunct Assistant Professor of Economics at Hunter College of the City University of New York.

About Solazyme, Inc.:

Solazyme, Inc. is a renewable oil and bioproducts company that transforms a range of low-cost plant-based sugars into high-value oils. Headquartered in South San Francisco, Solazyme's renewable products can replace or enhance oils derived from the world's three existing sources – petroleum, plants and animal fats. Initially, Solazyme is focused on commercializing its products into three target markets: (1) fuels and chemicals, (2) nutrition and (3) skin and personal care.

For more information on the opportunity to have your CEO discuss your company, please call NASDAQ CEO Signature Series, 978/461-3141.

The NASDAQ CEO Signature Series logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=4839

 


Tags